Related Experiment Video

Updated: Jun 7, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
11:51

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

Second-generation substituted quinolines as anticancer drugs for breast cancer

Brian Heiniger1, Gunjan Gakhar, Keshar Prasain

  • 1Departments of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS 66506, USA.

Anticancer Research
|November 2, 2010
PubMed

Insights

A novel compound, PQ7, significantly enhances gap junctional inter-cellular communication (GJIC) in breast cancer cells. This enhancement led to reduced tumor growth and complete regression in preclinical models, indicating PQ7

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Cancer cells exhibit diminished gap junctional inter-cellular communication (GJIC).
  • Restoring GJIC presents a potential strategy for inhibiting cancer cell proliferation.

Purpose of the Study:

  • To investigate the anti-tumor effects of a novel substituted quinoline, PQ7.
  • To evaluate PQ7's impact on GJIC and tumor formation in T47D breast cancer cells.

Main Methods:

  • Scrape load/dye transfer assays were employed to quantify GJIC.
  • Colony growth assays assessed tumor formation.
  • In vivo efficacy was evaluated using T47D xenografts in nu/nu mice.

Main Results:

  • PQ7 at 500 nM significantly increased GJIC by 16-fold in T47D cells.
  • A 50% reduction in colony growth was observed with 100 nM PQ7.
  • PQ7 treatment resulted in 100% regression of T47D xenograft tumors in mice.

Conclusions:

  • PQ7 demonstrates potent anti-tumor activity against human breast cancer cells.
  • PQ7's mechanism involves enhancing GJIC and inhibiting tumor growth.
  • PQ7 shows promise as a therapeutic agent for breast cancer treatment.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...